Giving back.
Our deep commitment to charitable endeavors comes from our belief that our ultimate purpose lies in something greater than ourselves; something greater than just running a successful business. Here are some of the ways we try to make a difference:
Hospital Sisters Mission Outreach - Hospital Sisters of St. Francis, Springfield, IL
The Mission Outreach program from the Hospital Sisters of St. Francis in Springfield, IL provides needed medical supplies to hospitals and clinics in over 75 countries. The medical equipment and supplies come from the donation that partnering hospitals make when they have a surplus of any one supply. Through these partnerships, the Hospital Sisters Mission Outreach program is able to deliver requested equipment and supplies such as syringes, gauze, anesthesia, beds, and much more. The program is in the process of expanding to Chicago and beyond.
Nettelhorst School / Chicago Public School System
Nettelhorst School attracts students from a range of socio-economic situations, from professional families to those from disadvantaged backgrounds. Their diversity is important to The Nash Group as it supports our belief that all students deserve the opportunity to grow both academically and socially. Nettelhorst School is frequently featured on CBS, PBS, NPR, 60 Minutes, The New York Times as an example of innovation and renewal in urban public schools.
Visitation Catholic School
Visitation Catholic School is located in Chicago’s Englewood neighborhood, where 25% of the residents are unemployed and 36% live below the poverty level. These students are at risk for academic failure because they had few options beyond enrolling in neighboring schools, which are commonly characterized by high dropout rates, crime, deteriorating physical plants and low academic achievement. The Nash Group supports the Dominican Sisters of Sinsinawa, Wisconsin who staff Visitation and the guidance they provide to all their students.
Advocate South Suburban Hospital
According to the American Heart Association/American Stroke Association, stroke is one of the leading causes of death and serious, long-term disability in the United States. On average, someone suffers a stroke every 40 seconds; someone dies of a stroke every four minutes; and 795,000 people suffer a new or recurrent stroke each year. Advocate South Suburban Hospital is recognized by the American Heart Association/American Stroke Association’s Get With The Guidelines®–Stroke Bronze Quality Achievement Award. The award recognizes hospitals that are successful in implementing a higher standard of stroke care by ensuring that stroke patients receive treatment according to nationally accepted standards and recommendations. As a group of health professionals, The Nash Group understands that patients treated in hospitals participating in the American Heart Association’s Get With The Guidelines-Heart Failure program receive a higher quality of care and may experience better outcomes and we support Advocate South Suburban hospital’s continued work in the field of stroke recognition and recovery.
Northwestern School of Medicine - The Miller Lab
The Nash Group supports The Miller Lab and we encourage others to do the same. Named for Dr. Stephen Miller, Professor and Director of the Interdepartmental Immunobiology Center at the Northwestern School of Medicine, we are grateful for their commitment to research on multiple sclerosis (MS). In MS, the immune system attacks and destroys myelin, the insulating layer that forms around nerves in the spinal cord, brain and optic nerve. When the insulation is destroyed, electrical signals can’t be effectively conducted, resulting in symptoms that range from mild limb numbness to paralysis or blindness. In 2013, Dr. Miller, the co-senior author of a paper on the study, which was published June 5 in the journal Science Translational Medicine. The study is a collaboration between Northwestern’s Feinberg School, University Hospital Zurich in Switzerland and University Medical Center Hamburg-Eppendorf in Germany. The human trial is the translation of more than 30 years of pre-clinical research in Miller's lab. “The therapy stops autoimmune responses that are already activated and prevents the activation of new autoimmune cells,” said Stephen Miller, the Judy Gugenheim Research Professor of Microbiology-Immunology at Northwestern University Feinberg School of Medicine. “Our approach leaves the function of the normal immune system intact. That’s the holy grail.” The Nash Group applauds the Miller Lab and we encourage others to support their research. See more here.